DEFINITIVE PROXY STATEMENT

Company

KIORA PHARMACEUTICALS INC

Filed

April 30, 2019

Period of Report

June 20, 2019

Accession Number

0001144204-19-022369

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →